Cargando…
Expression of activator protein-1 in papillary thyroid carcinoma and its clinical significance
BACKGROUND: The abnormal expression of activator protein-1(AP-1) has recently been investigated in a variety of tumors. While the relationship between AP-1 and thyroid cancer is poorly studied, our study was to evaluate the protein expression and clinical value of AP-1 in papillary thyroid carcinoma...
Autores principales: | Xiao, Cheng, Huang, Yonglian, Gao, Qiyuan, Feng, Zijian, Li, Qi, Liu, Zhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357454/ https://www.ncbi.nlm.nih.gov/pubmed/30704487 http://dx.doi.org/10.1186/s12957-019-1568-x |
Ejemplares similares
-
Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients
por: Liu, Chenxi, et al.
Publicado: (2019) -
Downregulation of SMOC2 expression in papillary thyroid carcinoma and its prognostic significance
por: Kim, Hye Sung, et al.
Publicado: (2020) -
Expression Profile and Clinical Significance of MicroRNAs in Papillary Thyroid Carcinoma
por: Peng, You, et al.
Publicado: (2014) -
Expression and Clinical Significance of Thyroid-stimulating hormone receptor in the Subtypes of Papillary thyroid carcinomas
por: Shen, Wei, et al.
Publicado: (2023) -
Significance of DMBT1 in Papillary Thyroid Carcinoma Concurrent With Hashimoto’s Thyroiditis
por: Gan, Xiao-xiong, et al.
Publicado: (2021)